Since the primary material was not reviewed and the molecular features of cyclin D1-negative MCL were not present, the panel considered this as compatible with relapsed primary cutaneous DLBCL, leg type with an unusual phenotype. This evidence concerns the gene CCND1 and mantle cell lymphoma.